Open Access
Issue
J Oral Med Oral Surg
Volume 29, Number 4, 2023
Article Number 40
Number of page(s) 5
DOI https://doi.org/10.1051/mbcb/2023037
Published online 23 January 2024
  1. Campana F, Lan R, Girard C, Rochefort J, Le Pelletier F, Leroux-Villet C, et al. French guidelines for the management of oral lichen planus (excluding pharmacological therapy). Ann Dermatol Vénéréologie. mars 2022;149:14–27. [CrossRef] [Google Scholar]
  2. Loyal J, Rashtak S. Vulvar lichen planus pemphigoides. Int J Womens Dermatol. déc 2017;3:225–227. [CrossRef] [Google Scholar]
  3. Zaraa I, Mahfoudh A, Sellami MK, Chelly I, El Euch D, Zitouna M, et al. Lichen planus pemphigoides: four new cases and a review of the literature. Int J Dermatol. avr 2013;52:406–412. [CrossRef] [PubMed] [Google Scholar]
  4. Sultan A, Stojanov IJ, Lerman MA, Kabani S, Haber J, Freedman J, et al. Oral lichen planus pemphigoides: a series of four cases. Oral Surg Oral Med Oral Pathol Oral Radiol. juill 2015;120:58–68. [CrossRef] [Google Scholar]
  5. Hodgson TA, Sahni N, Kaliakatsou F, Buchanan JAG, Porter SR.Long-term efficacy and safety of topical tacrolimus in the management of ulcerative/erosive oral lichen planus. Eur J Dermatol EJD. 2003;13:466–470. [Google Scholar]
  6. Eisen D. Hydroxychloroquine sulfate (Plaquenil) improves oral lichen planus: an open trial. J Am Acad Dermatol. avr 1993;28:609–612. [CrossRef] [Google Scholar]
  7. Benzaquen M, Suter VGA, Gschwend M, Feldmeyer L, Borradori L. Mucous membrane pemphigoid of the oral lichen type: a retrospective analysis of 16 cases. J Eur Acad Dermatol Venereol [Internet. mai 2019 [cité 12 oct 2023];33(5). Disponible sur: https://onlinelibrary.wiley.com/doi/10.1111/jdv.15473 [Google Scholar]
  8. Hübner F, Langan EA, Recke A. Lichen planus pemphigoides: from lichenoid inflammation to autoantibody-mediated blistering. Front Immunol. 2019;10:1389. [CrossRef] [Google Scholar]
  9. Fricain JC, Sibaud V, Campana F, Lepreux S, Taïeb A. Mucosal pigmentation after oral lichen planus treatment with topical tacrolimus. Dermatol Basel Switz. 2005;210:229–232. [CrossRef] [PubMed] [Google Scholar]
  10. Lee HY, Blazek C, Beltraminelli H, Borradori L. Oral mucous membrane pemphigoid: complete response to topical tacrolimus. Acta Derm Venereol. sept 2011;91:604–605. [CrossRef] [PubMed] [Google Scholar]
  11. Assmann T, Becker J, Ruzicka T, Megahed M. Topical tacrolimus for oral cicatricial pemphigoid. Clin Exp Dermatol. nov 2004;29:674–676. [CrossRef] [PubMed] [Google Scholar]
  12. Bendas ER, Abdullah H, El-Komy MHM, Kassem MAA. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus. Int J Pharm. 31 déc 2013;458:287–295. [CrossRef] [Google Scholar]
  13. Platais C, Lalagianni N, Momen S, Ormond M, McParland H, Setterfield J. Efficacy of hydroxychloroquine in oral lichen planus: a retrospective review. Br J Dermatol. 30 mars 2023;188:557–558. [CrossRef] [PubMed] [Google Scholar]
  14. Bhanja DB, Sil A, Chandra A, Biswas SK. Addisonian-like acrofacial hyperpigmentation following long-term hydroxychloroquine therapy in oral lichen planus. BMJ Case Rep. 28 janv 2021;14:e240727. [CrossRef] [Google Scholar]
  15. Pemphigoïde cicatricielle (PC), Texte du Protocole National de Diagnostic et de Soins (PNDS), Centres de référence des maladies bulleuses auto- immunes, Avril 2016. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.